ARTICLE | Clinical News
Brovana arformoterol tartrate: Phase II data
October 29, 2007 7:00 AM UTC
In an open-label Phase II trial in 39 patients, 15 µg of Brovana showed improvements in FEV1 that were similar to racemic formoterol. Data were presented at the American College of Chest Physicians me...